715 Early 18F-FDG PET/CT as predictive marker of treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab. (September 2015) - Skougaard, K.; Nielsen, D.; Jensen, B. Vittrup; Pfeiffer, P.; Hendel, H. Westergren